VUF-11222

CAS No. 1414376-84-3

VUF-11222( —— )

Catalog No. M34735 CAS No. 1414376-84-3

VUF-11222 is a CXCR3 nonmimetic peptide agonist that induces gliosis.VUF 11222 has been used in the study of retinal inflammation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 217 Get Quote
5MG 331 Get Quote
10MG 494 Get Quote
25MG 776 Get Quote
50MG 1067 Get Quote
100MG 1413 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VUF-11222
  • Note
    Research use only, not for human use.
  • Brief Description
    VUF-11222 is a CXCR3 nonmimetic peptide agonist that induces gliosis.VUF 11222 has been used in the study of retinal inflammation.
  • Description
    VUF 11222 (Compound 38) is a CXCR3 non-peptide-like agonist. VUF 11222 can be used in the study of inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    CXCR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1414376-84-3
  • Formula Weight
    552.33
  • Molecular Formula
    C25H31BrIN
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([N+](CC1=CC=C(C=C1)C2=C(Br)C=CC=C2)(C)C)C=3[C@]4(C(C)(C)[C@](C4)(CC3)[H])[H].[I-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wijtmans M, et al. Chemical subtleties in small-molecule modulation of peptide receptor function: the case of CXCR3 biaryl-type ligands. J Med Chem. 2012 Dec 13;55(23):10572-83.?
molnova catalog
related products
  • VUF-11222

    VUF-11222 is a CXCR3 nonmimetic peptide agonist that induces gliosis.VUF 11222 has been used in the study of retinal inflammation.

  • ML339

    ML339 a selective inhibitor of CXCR6(IC50 = 140 nM) with no response when screened against CXCR5 and CXCR4.

  • CTCE 9908

    CXCR4 antagonist; induces mitotic catastrophe in ovarian cancer cells. Displays additive cytotoxic effects when given with taxol. Enhances the efficacy of docetaxel in a mouse model.